The reversible inhibition of calcineurin (CaN), which is the only Ca 2؉ /calmodulin-dependent protein Ser/Thr phosphatase, is thought to be a key functional event for most cyclosporin A (CsA)-and tacrolimus (FK506)-mediated biological effects. In addition to CaN inhibition, however, CsA and FK506 have multiple biochemical effects because of their action in a gain-of-function model that requires prior binding to immunophilic proteins. We screened a small molecule library for direct inhibitors of CaN using CaN-mediated dephosphorylation of 33 P-labeled 19-residue phosphopeptide substrate (RII phosphopeptide) as an assay and found the polyphenolic aldehyde gossypol to be a novel CaN inhibitor. Unlike CsA and FK506, gossypol does not require a matchmaker protein for reversible CaN inhibition with an IC 50 value of 15 M. Gossypolone, a gossypol analog, showed improved inhibition of both RII phosphopeptide and p-nitrophenyl phosphate dephosphorylation with an IC 50 of 9 and 6 M, respectively. In contrast, apogossypol hexaacetate was inactive. Gossypol acts noncompetitively, interfering with the binding site for the cyclophilin 18⅐CsA complex in CaN. In contrast to CsA and FK506, gossypol does not inactivate the peptidyl-prolyl-cis/ trans-isomerase activity of immunophilins. Similar to CsA and FK506, T cell receptor signaling induced by phorbol 12-myristate 13-acetate/ionomycin is inhibited by gossypol in a dose-dependent manner, demonstrated by the inhibition of nuclear factor of activated T cell (NFAT) c1 translocation from the cytosol into the nucleus and suppression of NFAT-luciferase reporter gene activity.In vivo inhibition by membrane-penetrable low molecular mass compounds plays an important role in evaluating the biological function of enzymes involved in protein phosphorylation/dephosphorylation. The functional discrimination with specific inhibitors of the four major protein Ser/Thr phosphatases, protein phosphatase 1 (PP1), 1 protein phosphatase 2A (PP2A), protein phosphatase 2B (PP2B, calcineurin, CaN), and protein phosphatase 2C (PP2C), has proven to be successful (1). Okadaic acid and microcystin are strong inhibitors of PP1 and PP2A, but they exhibit poor inhibition of the Ca 2ϩ /calmodulinregulated CaN and PP2C. It was difficult to identify CaN function in cell signaling until the membrane-penetrable cyclopeptide cyclosporin A (CsA) and the peptidomacrolide FK506 were found to inhibit CaN specifically under certain conditions (2). Currently, most reports about CaN involvement in cellular processes are based on CsA and FK506 susceptibility of the appropriate bioassays. CaN inhibition by these drugs is characterized by their prior binding to the 18-kDa cyclophilin (Cyp18) and 12-kDa FK506-binding protein (FKBP12), respectively, indicating a gain-of-function mechanism (3). These mammalian prototypes of two different families of the enzyme class of peptidyl-prolyl-cis/trans-isomerases (EC 5.2.1.8; PPIases) function as molecular matchmakers because the drugs cannot bind to CaN on their own. The prototypic P...